Skip to main content

Evaluation of Co-occurring Psychiatric Disorders and Cannabis Use in the Outpatient Setting

  • Chapter
  • First Online:
Cannabis in Psychiatric Practice

Part of the book series: Psychiatry Update ((PU,volume 3))

  • 441 Accesses

Abstract

In the outpatient mental health setting, patients initially present with a wide variety of symptomatic complaints, seeking appropriate diagnosis and treatment recommendations. Such patients are typically at elevated risk of concurrently using cannabis, either identifying it as a recreational substance or even as a “treatment” for their underlying distress. Psychiatrists, in contrast, often recognize that despite the patient’s attitude toward cannabis, evidence-based literature indicates that it is more likely to exacerbate rather than ameliorate psychopathology. This chapter will delineate recommendations for comprehensively evaluating the relationship between the patient’s cannabis use and psychiatric history in the outpatient setting, incorporating both formal and informal screening tools. Furthermore, this chapter will focus on adopting a nonjudgmental approach in order to optimize therapeutic alliance and set the stage for managing potentially problematic cannabis use.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Burns RM, Caulkins JP, Everingham SS, Kilmer B. Statistics on cannabis users skew perceptions of cannabis use. Front Psych. 2013;6(4):138.

    Google Scholar 

  2. Carliner H, Brown QL, Sarvet AL, Hasin DS. Cannabis use, attitudes, and legal status in the US: a review. Prev Med. 2017;1(104):13–23.

    Article  Google Scholar 

  3. Center for Substance Abuse Treatment. Chapter 4: Screening and assessment. In: Substance abuse treatment: addressing the specific needs of women. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2009. Treatment Improvement Protocol (TIP) Series, No. 51. Available from: https://www.ncbi.nlm.nih.gov/books/NBK83253/. Accessed: 29 June 21.

  4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association: Arlington, VA; 2013.

    Book  Google Scholar 

  5. Cascini F, Aiello C, Di Tanna G. Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis. Curr Drug Abuse Rev. 2012;5(1):32–40.

    Article  CAS  Google Scholar 

  6. Mariani JJ, Brooks D, Haney M, Levin FR. Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend. 2011;113(2–3):249–51.

    Article  Google Scholar 

  7. Murray RM, Englund A, Abi-Dargham A, Lewis DA, Di Forti M, Davies C, Sherif M, McGuire P, D’Souza DC. Cannabis-associated psychosis: neural substrate and clinical impact. Neuropharmacology. 2017;15(124):89–104.

    Article  Google Scholar 

  8. National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press; 2017. https://doi.org/10.17226/24625.

    Book  Google Scholar 

  9. Adamson SJ, Sellman JD. A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev. 2003;22(3):309–15.

    Article  Google Scholar 

  10. Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, Sellman JD. An improved brief measure of cannabis misuse: the Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1–2):137–43.

    Article  Google Scholar 

  11. Legleye S, Karila L, Beck F, Reynaud M. Validation of the CAST, a general population Cannabis Abuse Screening Test. J Subst Abus. 2007;12(4):233–42.

    Google Scholar 

  12. Humeniuk RE, Henry-Edwards S, Ali RL, Poznyak V, Monteiro M. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization; 2010.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sirish Veligati .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Veligati, S., Ritvo, A. (2022). Evaluation of Co-occurring Psychiatric Disorders and Cannabis Use in the Outpatient Setting. In: Riggs, P., Thant, T. (eds) Cannabis in Psychiatric Practice. Psychiatry Update, vol 3. Springer, Cham. https://doi.org/10.1007/978-3-031-04874-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-04874-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-04873-9

  • Online ISBN: 978-3-031-04874-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics